New York City-based Hospital for Special Surgery engaged Intelliseq, a genomic data science company, to support orthopedic research, according to a May 7 news release.
HSS will use Intelliseq’s whole genome sequencing and bioinformatics capabilities for research on genetic and clinical factors in spine surgery.
The work will integrate genomic data with clinical and demographic information to help create predictive models that may inform future clinical decisionmaking.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
